🍂 Enjoy the Fall Season! 🍂
MindTheDesk

Novo Nordisk shares dive 9% after heart medicine fails trial

Business Archived • July 31, 2026 • 5 views
The experimental medicine ziltivekimab didn't translate into a statistically meaningful reduction in major cardiovascular adverse events, Novo said Friday.
Source: https://search.cnbc.com/rs/search/combinedcms/view.xml?partnerId=wrss01&id=100003114 - Read Original
"Adventure is where you chose to go."
"Monetize your website or boost your business with Code-Oryx. Join the network today!"

Discussion (0)

Please log in to post a comment.

No comments yet. Be the first to share your thoughts!

Sponsored
"Camping the Easyway"
"Output is a realization of Input."